About PT-141
PT-141 (Bremelanotide) is a synthetic peptide studied as a melanocortin receptor agonist in neuroscience and receptor pharmacology research. Supplied as a lyophilized powder for laboratory investigations into melanocortin signaling pathways and CNS-associated signaling mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling.
Recent research on PT-141: Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling.
Read Full Study on PubMedStrategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.
Recent research on PT-141: Strategies for Treating Sexual Health Concerns After Breast and Gynecologic Cancer.
Read Full Study on PubMedAdditional Studies
Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.
Recent research on PT-141: Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.
Read on PubMedShould Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?
Recent research on PT-141: Should Bremelanotide Be Considered for the Treatment of Sexual Arousal and Desire Disorders in Men?
Read on PubMedFDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
Recent research on PT-141: FDA-Approved Drugs Containing D-Amino Acids: A Historical and Developmental Perspective.
Read on PubMedClinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov.
Recent research on PT-141: Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov.
Read on PubMedFemale Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Recent research on PT-141: Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment Options.
Read on PubMedQuantification of "Mercy Sex" in Heterosexual Women.
Recent research on PT-141: Quantification of "Mercy Sex" in Heterosexual Women.
Read on PubMedRelated Research
Purchase PT-141 from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.